Mice Model Market Overview
The Mice Model Market is expanding as pharmaceutical companies, biotechnology firms, and research institutions increasingly rely on animal models for drug discovery, disease research, genetic studies, and personalized medicine. Advances in genetic engineering, CRISPR-based technologies, and the development of more precise disease models are improving the relevance and utility of mice in biomedical research.
According to the Market Research Future report updated August 27, 2026, the Mice Model Market was valued at USD 1.677 billion in 2024 and is projected to grow from USD 1.781 billion in 2025 to USD 3.251 billion by 2035, registering a CAGR of 6.2% during 2025–2035. North America remains the largest regional market with approximately 45% of global share, while Asia-Pacific is emerging as the fastest-growing region. Genetically Engineered Mice represent the largest model-type segment, while Inbred Mice are the fastest-growing. Breeding is the largest service category, while Cryopreservation is the fastest-growing. CRISPR/CAS9 holds the largest technology share, while Microinjection is growing rapidly. Oncology represents the largest therapeutic area, while Immunology is the fastest-growing. Drug Discovery & Development is the largest application, while Personalized Medicine is the fastest-growing application.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.marketresearchfuture.com/reports/mice-model-market-21972
Key players driving innovation and competitiveness in the Mice Model Market include:
Charles River Laboratories
The Jackson Laboratory
Taconic Biosciences
Envigo
Harlan Laboratories
Crown Bioscience
Janvier Labs
InVivo Biosystems
GenOway
The Mice Model Market is being shaped by advancements in genetic engineering, growing demand for more representative preclinical models, and increasing investment in drug discovery and biomedical research. Genetically modified mice are enabling researchers to replicate specific human disease mechanisms and evaluate potential therapeutic targets. The market is also seeing increased interest in humanized mice and alternative research models such as organoids, which can complement traditional animal models. Growing research into oncology, chronic diseases, immunology, and personalized medicine is further supporting demand for specialized mice models and associated services.
The Mice Model Market can be segmented by model type, service, technology, therapeutic area, application, and end user. By model type, the market includes Inbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, and Outbred Mice. By service, it covers Breeding, Cryopreservation, Rederivation, Quarantine, and Other Services. Technologies include CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer, and Other Technologies. Therapeutic areas include Oncology, Metabolic Diseases, Immunology, Neurology, and Cardiovascular Diseases. Applications include Drug Discovery & Development, Research Application, and Personalized Medicine, while end users include Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and CROs & CDMOs.
Opportunities are emerging through the development of genetically engineered models for specific diseases, expansion of contract research services, AI-assisted research analysis, and customized mice models for precision medicine. Increasing government and private-sector funding for biomedical research is creating additional demand for specialized models. The expansion of biotechnology research across Asia-Pacific, particularly in China and India, also offers opportunities for suppliers of advanced mouse models, breeding services, and genetic engineering technologies.
Recent Developments and Market Trends:
Advances in CRISPR/CAS9 and other gene-editing technologies are enabling researchers to create increasingly precise genetically engineered mouse models for disease and therapeutic research.
Personalized medicine is increasing demand for mice models that can replicate specific genetic variations and disease characteristics relevant to individual patient populations.
Humanized mice and organoids are gaining attention as complementary research approaches that can provide additional insights into human biology and therapeutic responses.
Contract research organizations and specialized model providers are expanding services for breeding, genetic engineering, cryopreservation, and preclinical research to support pharmaceutical and biotechnology companies.
Artificial intelligence and advanced data-analysis technologies are increasingly being integrated into biomedical research workflows to improve the interpretation of experimental results and accelerate model-based research.
Reasons to Buy the Report:
Understand the market size, growth trajectory, CAGR, and forecast valuation through 2035.
Identify the dominant and fastest-growing model type, service, technology, therapeutic-area, and application segments.
Evaluate North America’s market leadership and Asia-Pacific’s rapidly expanding research ecosystem.
Analyze the competitive landscape and strategies of leading mice model providers and research organizations.
Assess opportunities in genetically engineered models, CRISPR technologies, personalized medicine, CRO services, and AI-assisted research.
Future Outlook:
The Mice Model Market is expected to maintain steady growth through 2035 as advances in genetic engineering, rising pharmaceutical R&D investment, and increasing demand for personalized medicine continue to expand applications for preclinical models. Genetically Engineered Mice are expected to remain the largest model-type category because of their broad use in disease modeling, genetic studies, and drug development, while Inbred Mice are projected to experience the fastest growth because their standardized genetic backgrounds support reproducible experimental outcomes. Breeding will remain the largest service segment because of the continuing need to develop and maintain specialized strains, while Cryopreservation is positioned as the fastest-growing service as researchers increasingly seek efficient long-term preservation of valuable genetic material. CRISPR/CAS9 is expected to retain its leading technology position because of its precision and versatility, while Microinjection is projected to expand as researchers seek efficient methods for introducing genetic material into embryos. Oncology will remain the largest therapeutic area, supported by extensive cancer research and demand for tumor-specific models, while Immunology is expected to grow rapidly as research into autoimmune diseases and immunotherapies expands. Drug Discovery & Development will remain the largest application, while Personalized Medicine is projected to be the fastest-growing as research increasingly focuses on patient-specific genetic characteristics and targeted therapies. Pharmaceutical and Biotechnology Companies will continue to represent the largest end-user group, while Academic & Research Institutes are expected to experience the fastest growth. North America is expected to retain its leadership with approximately 45% of the global market, supported by strong biotechnology investment and established research infrastructure, while Asia-Pacific is projected to remain the fastest-growing region as pharmaceutical research, biotechnology investment, and research infrastructure expand. Overall, the Mice Model Market is projected to reach USD 3.251 billion by 2035 at a CAGR of 6.2%.
➤➤Explore Our Latest Related Reports:
